A global intelligence publication covering biotechnology, artificial intelligence, drug discovery, synthetic biology, and life-science innovation.
The Great Therapeutic Divide
The Strathmore 2026 Report
Join leaders, innovators and professionals across artificial intelligence and biotechnology for an evening focused on industry insights, new connections and meaningful collaboration.
BIOCENTURY | REGULATIONWIDESPREAD ATROPINE USE FAILS TO SWAY FDA ADVISORS ON SYDNEXIS DATAPanel favors another trial to establish meaningful benefit…
Read Article →
PLYMOUTH MEETING, Pa., Oct. 30, 2026 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA…
Read Article →
According to the company, the funds will support the next phase of its growth in enabling autonomous science in labs…
Read Article →
Learn more about FDA's Postmarketing Requirements and Commitments Searchable Database.
Read Article →
Focused on ensuring growth beyond Dupixent, Sanofi wants to acquire derisked assets that may benefit from the French pharma’s commercial…
Read Article →
Anthropic is setting the stage for the largest IPO in history and Akeso has been touting its latest positive results…
Read Article →
AstraZeneca has launched a three-year cost-cutting program that aims to slice off $1.5 billion a year, with the savings reinvested…
Read Article →
Aspen Neuroscience and Bambusa Therapeutics get their Nasdaq IPOs over the line, while Corxel eyes a debut via a blank-cheque…
Read Article →
The most dangerous antimicrobial-resistant (AMR) pathogens in America are causing an estimated 9.7 million infections and 50,800 deaths in the U.S. each year, says […] The post CDC report details…
Read Article →
Etiome, Cellarity and Empress Therapeutics are being combined into one new AI-aided drugmaker claiming to possess the ability to better…
Read Article →
Most microbes remain out of reach, and many antibiotic-producing genes stay silent. A new review argues that combining genomics, innovative…
Read Article →
Astellas Pharma could secure the exclusive global rights to Audax Biosciences’ DAX-044, an antibody-cytokine fusion therapy that activates the immune…
Read Article →
Researchers report an immune-enhanced boron neutron capture therapy platform that achieved high intratumor boron-10 levels and a model-estimated 99.6 percent…
Read Article →BIOCENTURY | POLITICS, POLICY & LAWAUCHINCLOSS BILL SEEKS TO IMPROVE ‘OPERATING SYSTEM FOR SCIENCE’Bill creates infrastructure to embed trials in routine care, establish Australia-style notification scheme for Phase I, build…
Read Article →
A retrospective analysis of primary care electronic health records found stigmatizing language in 45.3 percent of clinical notes, with higher…
Read Article →
Ono Pharma’s ONO-1110 failed five Phase 2 trials, leading to the discontinuation of development in depression and social anxiety. Work…
Read Article →
Preclinical study results suggest how the heart can keep itself well-fueled even under times of stress, by burning glucose in…
Read Article →
INDIANAPOLIS, Oct 28, 2026 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY), the maker of Mounjaro (tirzepatide) and Foundayo (orforglipron),…
Read Article →BIOCENTURY | REGULATIONWIDESPREAD ATROPINE USE FAILS TO SWAY FDA ADVISORS ON SYDNEXIS DATAPanel favors another trial to establish meaningful benefit in pediatric myopia despite clinicians’ support for approval
Read Article →PLYMOUTH MEETING, Pa., Oct. 30, 2026 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA…
Read Article →Learn more about FDA's Postmarketing Requirements and Commitments Searchable Database.
Read Article →
BIO praised a Food and Drug Administration (FDA) initiative targeting more tailored, patient-centered, and predictable development of rare disease drugs,…
Read Article →
RFK Jr. has given notice that the agency won’t take enforcement action on six peptides that controversially won a contested…
Read Article →
BIOCENTURY | FINANCEWHAT MADE ESTUARY’S KIDNEY GENE THERAPY BET INVESTABLEA $93M series A backs the prospect of a one-time treatment as pharmas advance competing modalities in ADPKD
Read Article →
Liu ensured that his return visit to ESGCT (having spoken at the congress in Barcelona in 2019) would be one…
Read Article →
In part three of our series, I spoke with Ryan Confer, President and CEO of Genprex, about the company’s move…
Read Article →
A new review argues that some non-coding RNAs produce functional peptides and act as bifunctional regulatory units in cardiovascular disease.
Read Article →
Nature Biotechnology, Published online: 28 October 2026; doi:10.1038/s41587-026-03343-6Dairy cows are protected from H5N1 influenza by an mRNA vaccine.
Read Article →
AstraZeneca has launched a three-year cost-cutting program that aims to slice off $1.5 billion a year, with the savings reinvested in R&D.
Read Article →
FDA is engaged in efforts to encourage innovations in manufacturing processes and technology and to foster a quality management system.
Read Article →
In developing fetuses, the human brain generates an excess of neurons, most of which are eliminated around when the baby…
Read Article →
As companies invest billions of dollars to reshore manufacturing, 10 biotech and pharma businesses are reportedly trimming staff at manufacturing…
Read Article →
Lonza brings over 40 years of experience in microbial manufacturing, spanning pilot-scale development through commercial production. The post The stranded…
Read Article →
According to the company, the funds will support the next phase of its growth in enabling autonomous science in labs and biopharmaceutical companies using its AI and robotics systems. The…
Read Article →
BIOCENTURY | FINANCETHE IMPACT OF GILDE’S IMPACT COUNCIL WITH JOEP MUIJRERS How Gilde’s outside expert panel and deeper patient engagement have…
Read Article →Focused on ensuring growth beyond Dupixent, Sanofi wants to acquire derisked assets that may benefit from the French pharma’s commercial…
Read Article →Anthropic is setting the stage for the largest IPO in history and Akeso has been touting its latest positive results…
Read Article →Aspen Neuroscience and Bambusa Therapeutics get their Nasdaq IPOs over the line, while Corxel eyes a debut via a blank-cheque…
Read Article →
International Council on Harmonisation - Safety
Read Article →
A genome-wide study of more than 140,000 UK Biobank surgery patients identified a PITX2 risk locus for postoperative atrial fibrillation…
Read Article →
BIOCENTURY | DATA BYTECO-CO DEALS MAY BE ONE CASUALTY OF THE COINS ACT FOR U.S. BIOTECHSProposed restrictions could curb U.S.…
Read Article →
Lilly shrugs off concerns about the effect of US drug pricing policies on its diabetes and weight loss drugs as…
Read Article →
In this episode of Denatured, you’ll hear from Jerome Barley, commercial director at Avion Medical and Ryan Klein, vice president,…
Read Article →
Parse Biosciences and Nomic Bio are partnering to create Cascade, a 100-million-cell multimodal dataset combining single-cell and proteomic data to advance AI-driven immune modeling, drug discovery, and therapeutic target identification.…
Read Article →
Flagship Pioneering has formed a new AI-focused biotech company, called Etcelera, by combining the platforms of three firms from its…
Read Article →
Parexel’s Stacy Hurt draws on her experience with chemotherapy and as a caregiver to spot patient burdens that AI-assisted protocol…
Read Article →
Nature Biotechnology, Published online: 26 October 2026; doi:10.1038/s41587-026-03369-wGiving AI a seat at the peer review table
Read Article →Receive curated biotechnology intelligence, executive interviews, and publication updates delivered to your inbox.
Scan to Read
